An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.
The public health institute stated that Lassa fever cases occur year-round, with peak transmission periods typically from October to May. The data for week nine of the year revealed that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results